peHUB First Read

This morning find out what private equity's comeback plan is, if it indeed needs one, how much Boston biotech has raised in offerings and what the lowdown is on 3i's restructuring plans.

31 January 2013•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail